What's new

Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised

Apr 14, 2025 - 09:24
 0
Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Mercedes-AMG CLE 53 2025 long-term test

Next Article

Kempinski Hotels Welcomes Hoda Tahoun as Chief Talent Officer

Related Posts

Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Herbal medicinal product: Crataegi folium cum flore, Crataegus monogyna Jacq. (Lindm.), C. laevigata (Poir.) DC. or their hybrids; C. pentagyna Waldst. et Kit. ex Willd.; C. azarolus L., F: Assessment finalised

Herbal medicinal product: Crataegi folium cum flore, Cr...

Apr 15, 2025  0

Management Board meeting: 13 March 2025, European Medicines Agency, Amsterdam, the Netherlands, 13 March 2025

Management Board meeting: 13 March 2025, European Medic...

Mar 12, 2025  0